Andrew Barraclough, vice-president of design at GSK discusses how designers in pharma have had to adapt to remote working conditions and why collaboration is still key.
We speak to Dr Sarah Halford, head of Medical Sciences, Cancer Research UK Centre for Drug Development about its latest virtual clinical trial and its Covid-19 efforts.
In this case study, Carl Brookes - vice president of Manufacturing & Supply Chain operations at Kindeva Drug Delivery & product commercialisation manager Francis Mackin explore what CDMOs should be doing to prepare for Brexit.
Fernando Geijo and Xavier Ruiz, manager of QA for R&D and QRD auditor, respectively, at Azbil Telstar discuss the importance of adopting good practices in clinical research.
EPM speaks to Rafael Teixeira, President of logistics suppliers World Courier and ICS about the challenges of distributing a Covid-19 vaccine after approval.
This In Conversation feature sees Dr Thomas Kofoed co-founder of Alphalyse speaking to Mani Krishnan, VP/GM of SCIEX about the work the company is doing to help improve biologic drug development.
EPM editor Reece Armstrong sits down with Panna Sharma, CEO of Lantern Pharma to discuss what an Initial Public Offering of $27 million means for the company and where this biopharma is headed next.
